| Market Cap | ₹4,09,626Cr |
| ROE | 15.13% |
| P/E Ratio(TTM) | 39.40 |
| EPS(TTM) | 43.33 |
| P/B Ratio | 5.67 |
| Dividend Yield | 0.94% |
| Industry P/E | 34.63 |
| Book Value | 300.99 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
| Parent Organisation | Sun Pharmaceutical Industries Limited |
| Managing Director | NA |
| NSE Symbol | SUNPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cipla | NA (0.00%) | 22.47 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 17.40 | ||
| Mankind Pharma | NA (0.00%) | 51.83 | ||
| Zydus Lifesciences | NA (0.00%) | 20.95 |